Fund Name | Location |
Atsany Capital | - |
Cayuga Venture Fund | Ithaca, New York, United States |
EDC Capital | - |
Esplanade Ventures | Canada, Montréal, Quebec |
Fondazione Telethon | Italy, Lombardia, Milano |
General Motors | Detroit, Michigan, United States |
Greystone Managed Investments | Canada, Regina, Saskatchewan |
Haoyu Guquan | China, Shaanxi, Yanan |
Huazhen Equity Investment | Beijing, Beijing, China |
IDFC Private Equity | India, Maharashtra, Mumbai |
Luobo She Investment | China, Hangzhou, Zhejiang |
Nokia Venture Partners | California, Kentucky, United States |
Pangaea Ventures | British Columbia, Canada, Vancouver |
Richland Equities | China, Guangdong, Shenzhen |
Severstal North America | Columbus, Mississippi, United States |
Terra Rossa Capital | Adelaide, Australia, South Australia |
The Department of Energy & Climate Change (DECC) | England, London, United Kingdom |
Valencia Institute of Finance | - |
Zongshen Power | China, Chongqing, Chongqing Shi |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Action Pharma | $17M | 17 Jan 2008 | Central Denmark Region |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Action Pharma | $17M | 17 Jan 2008 | Central Denmark Region |